application): This proposal aims to establish the feasibility of exploiting metal-siderophore transport systems in Mycobacterium tuberculosis as a route for the development of a new class of antibiotics. Mycobactins, exochelins, and other siderophores function to sequester essential metals, particularly iron, within bacteria. Their bactericidal activity against mycobacteria when complexed with toxic metals will be evaluated in normal and iron-deficient media. Existing proprietary solid-phase methodology will be adapted for the production of combinatorial libraries based on the mycobactins and the exochelins. The affinity of compounds in these libraries for toxic metals will be determined by novel high-throughput screening methods, and metal-siderophore complexes found to be stable will be assayed against a variety of bacterial strains to determine their potency as antibacterial agents.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI044584-01
Application #
2793436
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Program Officer
Laughon, Barbara E
Project Start
1999-08-15
Project End
2000-08-14
Budget Start
1999-08-15
Budget End
2000-08-14
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Metaphore Pharmaceuticals, Inc.
Department
Type
DUNS #
City
St. Louis
State
MO
Country
United States
Zip Code
63114
Poreddy, Amruta R; Schall, Otto F; Marshall, Garland R et al. (2003) Solid-phase synthesis of methyl carboxymycobactin T 7 and analogues as potential antimycobacterial agents. Bioorg Med Chem Lett 13:2553-6